Bruker (NASDAQ: BRKR) reported Q3 EPS of $0.74, $0.11 better than the analyst estimate of $0.63. Revenue for the quarter came in at $742.8 million versus the consensus estimate of $714.12 million.

GUIDANCE:

Bruker sees FY2023 EPS of $2.48-$2.53, versus the consensus of $2.57. Bruker sees FY2023 revenue of $2.88-2.91 billion, versus the consensus of $2.88 billion.

For earnings history and earnings-related data on Bruker (BRKR) click here.